Jubbonti Injection
Product Images NDC 61314-240

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Jubbonti (NDC 61314-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

A line graph comparing patient hip fracture incidence (%) over 36 study months between two groups: placebo (dashed line, N=3906) and denosumab (solid line, N=3902). The graph shows fracture incidence on the vertical axis and study month on the horizontal axis, with the placebo group showing higher incidence compared to denosumab over time.*

FDA Label Image

Image-1 (Image 01)

An instructional diagram of the JUBBONTI denosumab 60 mg/mL subcutaneous injection syringe, showing labeled parts before and after use. Before use, the syringe components include the plunger head, plunger, expiry date, viewing window, and needle cap. After use, the safety guard wings, safety guard, and needle are shown to illustrate the syringe's safety features post-injection.*

FDA Label Image

Image-2 (Image 02)

Illustration showing front and back views of a human figure with shaded areas on the abdomen and upper thighs, likely indicating recommended subcutaneous injection sites for denosumab injection.*

FDA Label Image

Image3 (Image 03)

An instructional illustration showing a hand holding a syringe injecting medication subcutaneously into the skin. The image demonstrates the injection technique for subcutaneous administration, likely representing the proper use of the JUBBONTI denosumab injection product.*

FDA Label Image

Image4 (Image 04)

An instructional diagram showing hands preparing a prefilled syringe of JUBBONTI (denosumab) injection for subcutaneous administration. The image highlights the removal of the cap from the syringe needle prior to injection.*

FDA Label Image

Image5 (Image 05)

An instructional diagram showing the use of a prefilled injection syringe, presumably JUBBONTI (denosumab) 60 mg/mL, for subcutaneous administration. The image depicts a hand holding the syringe at an angle to the skin, with a magnified view of the syringe barrel and measurement markings.*

FDA Label Image

Label (Image 06)

JUBBONTI 60 mg/mL injection label for denosumab by Sandoz Inc. It specifies a 1 x 60 mg single-dose prefilled syringe with a safety guard, intended for subcutaneous use only. The label includes medication guide dispensing instructions, the NDC 61314-240-63, and Sandoz branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.